http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2519196-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86de7d9f2e6454d7c2f6aeaf3b9541b6 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 2011-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9476298fe8fa312832665179e9181cf6 |
| publicationDate | 2014-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2519196-C2 |
| titleOfInvention | Therapeutic agent for treating pathological syndrome and method of treating multiple sclerosis |
| abstract | FIELD: medicine. n SUBSTANCE: present group of inventions refers to medicine, namely neurology, and concerns treating pathological syndrome specific for multiple sclerosis. That is ensured by administering a pharmaceutical composition containing an activated-potentiated form of human gamma-interferon (IFN-γ) antibodies and an activated-potentiated form of brain-specific protein S-100 antibodies. n EFFECT: therapeutic agent provides treating multiple sclerosis ensured by the synergetic action of the ingredients of the composition. n 9 cl, 2 ex, 1 tbl, 4 dwg |
| priorityDate | 2011-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 657.